
Niloofar Rahmani
Examiner (ID: 12602, Phone: (571)272-4329 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1691, 1621 |
| Total Applications | 2303 |
| Issued Applications | 1739 |
| Pending Applications | 128 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7535252
[patent_doc_number] => 08048878
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-01
[patent_title] => 'Two cyclic cinnamide compound'
[patent_app_type] => utility
[patent_app_number] => 12/403565
[patent_app_country] => US
[patent_app_date] => 2009-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 143464
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/048/08048878.pdf
[firstpage_image] =>[orig_patent_app_number] => 12403565
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/403565 | Two cyclic cinnamide compound | Mar 12, 2009 | Issued |
Array
(
[id] => 5527863
[patent_doc_number] => 20090197940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'CHONDROPSIN-CLASS ANTITUMOR V-ATPase INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/402560
[patent_app_country] => US
[patent_app_date] => 2009-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18310
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197940.pdf
[firstpage_image] =>[orig_patent_app_number] => 12402560
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/402560 | CHONDROPSIN-CLASS ANTITUMOR V-ATPase INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | Mar 11, 2009 | Abandoned |
Array
(
[id] => 6149961
[patent_doc_number] => 20110021556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'PYRROLIDINYL DERIVATIVES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/922656
[patent_app_country] => US
[patent_app_date] => 2009-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23843
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021556.pdf
[firstpage_image] =>[orig_patent_app_number] => 12922656
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/922656 | PYRROLIDINYL DERIVATIVES AND USES THEREOF | Mar 9, 2009 | Abandoned |
Array
(
[id] => 5502853
[patent_doc_number] => 20090163541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'QUINUCLIDINE COMPOUNDS HAVING QUATERNARY AMMONIUM GROUP, ITS PREPARATION METHOD AND USE AS BLOCKING AGENTS OF ACETYLCHOLINE'
[patent_app_type] => utility
[patent_app_number] => 12/400053
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2407
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163541.pdf
[firstpage_image] =>[orig_patent_app_number] => 12400053
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/400053 | Quinuclidine compounds having quaternary ammonium group, its preparation method and use as blocking agents of acetylcholine | Mar 8, 2009 | Issued |
Array
(
[id] => 5978146
[patent_doc_number] => 20110071180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'SUB-TYPE SELECTIVE AMIDES OF DIAZABICYCLOALKANES'
[patent_app_type] => utility
[patent_app_number] => 12/919970
[patent_app_country] => US
[patent_app_date] => 2009-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16462
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20110071180.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919970
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919970 | SUB-TYPE SELECTIVE AMIDES OF DIAZABICYCLOALKANES | Mar 3, 2009 | Abandoned |
Array
(
[id] => 6039438
[patent_doc_number] => 20110092487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'NOVEL 3,8-DIAZA-BICYCLO[3.2.1]OCTANE-AND 3,9-DIAZA-BICYCLO[3.3.1]-NONANE-3-CARBOXYLIC ACID ESTER DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/920965
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8626
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092487.pdf
[firstpage_image] =>[orig_patent_app_number] => 12920965
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/920965 | NOVEL 3,8-DIAZA-BICYCLO[3.2.1]OCTANE-AND 3,9-DIAZA-BICYCLO[3.3.1]-NONANE-3-CARBOXYLIC ACID ESTER DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS | Feb 26, 2009 | Abandoned |
Array
(
[id] => 6054529
[patent_doc_number] => 20110110889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'RAF INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/920045
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69686
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20110110889.pdf
[firstpage_image] =>[orig_patent_app_number] => 12920045
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/920045 | Raf inhibitor compounds and methods of use thereof | Feb 26, 2009 | Issued |
Array
(
[id] => 7988123
[patent_doc_number] => 08076356
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-13
[patent_title] => 'Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/371719
[patent_app_country] => US
[patent_app_date] => 2009-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 57802
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/076/08076356.pdf
[firstpage_image] =>[orig_patent_app_number] => 12371719
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/371719 | Triazolopyridinylsulfanyl derivatives as P38 map kinase inhibitors | Feb 15, 2009 | Issued |
Array
(
[id] => 6039487
[patent_doc_number] => 20110092536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'NOVEL ANTI-INFECTIOUS DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES OF SAID DERIVATIVES IN TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/866645
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11306
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092536.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866645
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866645 | Anti-infective derivatives, method for the production thereof, pharmaceutical compositions containing same and uses of said derivatives in treatment | Feb 5, 2009 | Issued |
Array
(
[id] => 5993582
[patent_doc_number] => 20110015235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'NOVEL PHENYLETHYNYL DERIVATIVES OF 8-AZA-BICYCLO[3.2.1]OCTANE AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/866044
[patent_app_country] => US
[patent_app_date] => 2009-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5125
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015235.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866044
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866044 | NOVEL PHENYLETHYNYL DERIVATIVES OF 8-AZA-BICYCLO[3.2.1]OCTANE AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS | Feb 3, 2009 | Abandoned |
Array
(
[id] => 6214323
[patent_doc_number] => 20110136854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'NOVEL 9-AZA-BICYCLO[3.3.1]NON-3-YLOXY CHROMEN-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/866093
[patent_app_country] => US
[patent_app_date] => 2009-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6860
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136854.pdf
[firstpage_image] =>[orig_patent_app_number] => 12866093
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866093 | NOVEL 9-AZA-BICYCLO[3.3.1]NON-3-YLOXY CHROMEN-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS | Feb 3, 2009 | Abandoned |
Array
(
[id] => 6617395
[patent_doc_number] => 20100324024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'Quinolizidinone M1 Receptor Positive Allosteric Modulators'
[patent_app_type] => utility
[patent_app_number] => 12/865975
[patent_app_country] => US
[patent_app_date] => 2009-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12855
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20100324024.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865975
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865975 | Quinolizidinone M1 receptor positive allosteric modulators | Feb 2, 2009 | Issued |
Array
(
[id] => 4613314
[patent_doc_number] => 07989469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-02
[patent_title] => 'Certain chemical entities, compositions, and methods'
[patent_app_type] => utility
[patent_app_number] => 12/364394
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24226
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/989/07989469.pdf
[firstpage_image] =>[orig_patent_app_number] => 12364394
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/364394 | Certain chemical entities, compositions, and methods | Feb 1, 2009 | Issued |
Array
(
[id] => 4444890
[patent_doc_number] => 07863269
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-01-04
[patent_title] => 'Imino-imidazo-pyridine derivatives having antithrombotic activity'
[patent_app_type] => utility
[patent_app_number] => 12/364124
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20086
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/863/07863269.pdf
[firstpage_image] =>[orig_patent_app_number] => 12364124
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/364124 | Imino-imidazo-pyridine derivatives having antithrombotic activity | Feb 1, 2009 | Issued |
Array
(
[id] => 14078
[patent_doc_number] => 07807837
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Scalable synthesis of imidazole derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/364089
[patent_app_country] => US
[patent_app_date] => 2009-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40361
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807837.pdf
[firstpage_image] =>[orig_patent_app_number] => 12364089
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/364089 | Scalable synthesis of imidazole derivatives | Feb 1, 2009 | Issued |
Array
(
[id] => 5480958
[patent_doc_number] => 20090203915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'Process for the preparation of solifenacin'
[patent_app_type] => utility
[patent_app_number] => 12/362506
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2145
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203915.pdf
[firstpage_image] =>[orig_patent_app_number] => 12362506
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/362506 | Process for the preparation of solifenacin | Jan 29, 2009 | Abandoned |
Array
(
[id] => 5502851
[patent_doc_number] => 20090163539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-25
[patent_title] => 'ENANTIOMER OF TENATOPRAZOLE AND THE USE THEREOF IN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/359410
[patent_app_country] => US
[patent_app_date] => 2009-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3790
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0163/20090163539.pdf
[firstpage_image] =>[orig_patent_app_number] => 12359410
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/359410 | Enantiomer of tenatoprazole and the use thereof in therapy | Jan 25, 2009 | Issued |
Array
(
[id] => 4619256
[patent_doc_number] => 07998976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-16
[patent_title] => 'Certain chemical entities, compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 12/359186
[patent_app_country] => US
[patent_app_date] => 2009-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14259
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/998/07998976.pdf
[firstpage_image] =>[orig_patent_app_number] => 12359186
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/359186 | Certain chemical entities, compositions and methods | Jan 22, 2009 | Issued |
Array
(
[id] => 5953689
[patent_doc_number] => 20110034334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'HERBICIDAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/863282
[patent_app_country] => US
[patent_app_date] => 2009-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25360
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20110034334.pdf
[firstpage_image] =>[orig_patent_app_number] => 12863282
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/863282 | Herbicidal compounds | Jan 15, 2009 | Issued |
Array
(
[id] => 6102630
[patent_doc_number] => 20110166123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'NOVEL COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/812022
[patent_app_country] => US
[patent_app_date] => 2009-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81465
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166123.pdf
[firstpage_image] =>[orig_patent_app_number] => 12812022
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/812022 | NOVEL COMPOSITIONS AND METHODS OF USE | Jan 6, 2009 | Abandoned |